State Street Corp Novartis Ag Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Novartis Ag stock. As of the latest transaction made, State Street Corp holds 1,695,309 shares of NVS stock, worth $165 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,695,309
Previous 1,753,974 3.34%
Holding current value
$165 Million
Previous $187 Million 4.43%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $6.23 Million - $7.09 Million
-58,665 Reduced 3.34%
1,695,309 $195 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $1.48 Million - $1.72 Million
16,020 Added 0.92%
1,753,974 $187 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $3.72 Million - $4.24 Million
-39,094 Reduced 2.2%
1,737,954 $168 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $1.89 Million - $2.09 Million
20,534 Added 1.17%
1,777,048 $179 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $3.25 Million - $3.61 Million
-34,349 Reduced 1.92%
1,756,514 $179 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $8.11 Million - $9.19 Million
-87,608 Reduced 4.66%
1,790,863 $181 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $791,176 - $917,519
-9,886 Reduced 0.52%
1,878,471 $173 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $2.94 Million - $3.6 Million
-38,920 Reduced 2.02%
1,888,357 $171 Million
Q3 2022

Nov 15, 2022
SELL
$74.61 - $87.26 $3.18 Million - $3.72 Million
-42,628 Reduced 2.16%
1,927,277 $146 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $575,315 - $669,843
7,145 Added 0.36%
1,969,905 $167 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $645,686 - $730,397
8,060 Added 0.41%
1,962,760 $172 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $4.83 Million - $5.34 Million
-60,564 Reduced 3.01%
1,954,700 $171 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $1.98 Million - $2.3 Million
-24,225 Reduced 1.19%
2,015,264 $165 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $2.79 Million - $3.08 Million
32,764 Added 1.63%
2,039,489 $186 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $2.13 Million - $2.52 Million
-25,566 Reduced 1.26%
2,006,725 $172 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $5.5 Million - $6.65 Million
-70,388 Reduced 3.35%
2,032,291 $192 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $2.59 Million - $2.87 Million
-31,565 Reduced 1.48%
2,102,679 $183 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $1.44 Million - $1.62 Million
17,817 Added 0.84%
2,134,244 $186 Million
Q1 2020

May 11, 2020
BUY
$70.67 - $99.01 $150 Million - $210 Million
2,116,427 New
2,116,427 $174 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email